BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+9.76%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$634M
AUM Growth
+$634M
(+4.5%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-5.02%
Top 10 Holdings %
Top 10 Hldgs %
52.68%
Holding
60
New
15
Increased
10
Reduced
19
Closed
10
Top Buys
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$27.1M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$18.7M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.1M |
| 4 |
KALA BIO
KALA
|
$10.8M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$9.2M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$30.8M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$30.7M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$24.1M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.9M |
| 5 |
AngioDynamics
ANGO
|
$14.2M |
Sector Composition
| 1 | Healthcare | 88.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $7.13M | 1.11% | +130,900 | New | +$7.13M |
|
|
NVLN
27
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $6.82M | 1.06% | 1,948,554 | – | – |
|
28
Sol-Gel Technologies
SLGL
$63.5M
| $6.67M | 1.04% | +647,700 | New | +$6.67M |
|
29
Vericel Corp
VCEL
$1.83B
| $6.56M | 1.02% | 658,900 +572,342 | +661% | +$5.69M |
|
30
Esperion Therapeutics
ESPR
$448M
| $6.28M | 0.98% | +86,786 | New | +$6.28M |
|
|
AMRN
31
Amarin Corp
AMRN
$311M
| $6.26M | 0.98% | 2,078,799 +928,350 | +81% | +$2.79M |
|
|
PRTK
32
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $6.21M | 0.97% | 477,607 +71,400 | +18% | +$928K |
|
|
TLGT
33
DELISTED
Teligent, Inc
TLGT
| $5.68M | 0.89% | 1,690,794 -234,621 | -12% | -$788K |
|
34
Pacira BioSciences
PCRX
$1.2B
| $5.19M | 0.81% | +166,500 | New | +$5.19M |
|
|
OXFD
35
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.66M | 0.73% | +374,233 | New | +$4.66M |
|
|
NTUS
36
DELISTED
Natus Medical Inc
NTUS
| $3.82M | 0.6% | 113,526 -90,874 | -44% | -$3.06M |
|
|
VAR
37
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.68M | 0.57% | +30,000 | New | +$3.68M |
|
|
NVTA
38
DELISTED
Invitae Corporation
NVTA
| $3.52M | 0.55% | +750,000 | New | +$3.52M |
|
39
Veracyte
VCYT
$2.39B
| $3.34M | 0.52% | 600,658 -145,700 | -20% | -$810K |
|
40
ADMA Biologics
ADMA
$4.12B
| $3.31M | 0.52% | 720,529 -381,671 | -35% | -$1.76M |
|
|
TTPH
41
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.22M | 0.5% | 1,048,642 +159,542 | +18% | +$490K |
|
42
MediWound
MDWD
$182M
| $2.6M | 0.41% | 500,000 | – | – |
|
43
SCYNEXIS
SCYX
$34.9M
| $2.53M | 0.39% | +1,885,904 | New | +$2.53M |
|
44
Cidara Therapeutics
CDTX
$1.66B
| $1.5M | 0.23% | 375,816 -481,581 | -56% | -$1.93M |
|
|
IVTY
45
DELISTED
Invuity, Inc
IVTY
| $1.15M | 0.18% | +298,800 | New | +$1.15M |
|
|
CFRX
46
DELISTED
ContraFect Corporation
CFRX
| $633K | 0.1% | 389,475 -842,191 | -68% | -$1.37M |
|
47
Tempest Therapeutics
TPST
$44M
| $442K | 0.07% | 545,282 -4,718 | -0.9% | -$3.82K |
|
48
Strata Skin Sciences
SSKN
$9.93M
| $238K | 0.04% | 203,346 | – | – |
|
49
Alphatec Holdings
ATEC
$2.35B
| – | – | -145,514 | Closed | -$387K |
|
50
Baxter International
BAX
$12.7B
| – | – | -65,300 | Closed | -$4.22M |
|